Gyre Therapeutics (GYRE) Change in Inventory (2023 - 2026)
Gyre Therapeutics (GYRE) posted quarterly Change in Inventory of $1.0 million for Q1 2026, down 34.13% year-over-year from $1.5 million in Q1 2025, and down 15.98% quarter-over-quarter from $1.2 million in Q4 2025.
Gyre Therapeutics (GYRE) Change in Inventory (2023 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Change in Inventory for 4 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 34.13% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $3.1 million (up 3.02% YoY), while the FY2025 annual figure was $3.6 million, up 69.75% from the prior year.
- Change in Inventory eased to $1.0 million in Q1 2026 per GYRE's latest filing, from $1.2 million in the prior quarter.
- Across five years, Change in Inventory topped out at $1.5 million in Q1 2025 and bottomed at -$921000.0 in Q3 2023.
- Historically, Change in Inventory has averaged $387538.5 across 4 years, with a median of $636000.0 in 2024.
- On a YoY basis, Change in Inventory climbed as much as 923.73% in 2025 and fell as far as 111.32% in 2025.
- Gyre Therapeutics' Change in Inventory stood at -$184000.0 in 2023, then surged by 164.13% to $118000.0 in 2024, then jumped by 923.73% to $1.2 million in 2025, then dropped by 15.98% to $1.0 million in 2026.
- Business Quant data shows GYRE's Change in Inventory at $1.0 million in Q1 2026, $1.2 million in Q4 2025, and -$72000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | -94,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -94,000.00 |
| Jun 30, 2026 | -94,000.00 |
| Mar 31, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | -72,000.00 |
| Sep 30, 2025 | -72,000.00 |
| Jun 30, 2025 | 954,000.00 |
| Jun 30, 2025 | 954,000.00 |
| Mar 31, 2025 | 1.54 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 118,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Sep 30, 2024 | 636,000.00 |
| Sep 30, 2024 | 636,000.00 |
| Jun 30, 2024 | 719,000.00 |
| Jun 30, 2024 | 719,000.00 |
| Mar 31, 2024 | 666,000.00 |
| Mar 31, 2024 | 666,000.00 |